Effect of chelerythrine against endotoxic shock in mice and its modulation of inflammatory mediators in peritoneal macrophages through the modulation of mitogen-activated protein kinase (MAPK) pathway

Inflammation

Volumn 35, Issue 6, 2012, Pages 1814-1824

  Li, Weifeng ^a   Fan, Ting ^a   Zhang, Yanmin ^a   Niu, Xiaofeng ^a   Xing, Wei ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Anti inflammatory effect; Chelerythrine; Mitogen activated protein kinase; Nitric oxide; TNF

Indexed keywords

CHELERYTHRINE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG SAFETY; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BENZOPHENANTHRIDINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; MALE; MAP KINASE SIGNALING SYSTEM; MICE; NITRIC OXIDE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SHOCK, SEPTIC; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE; MUS;

EID: 84872181334     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9502-1     Document Type: Article

References (50)

1. Walterova, D., J.U. lrichova, I. Valka, J. Vicar, C. Vavreckova, E. Taborska, R.J. Harkrader, D.L. Meyer, H. Cerna, and V. Simanek. 1995. Benzo [c] phenanthridine alkaloids sanguinarine and chelerythrine: biological activities and dental care applications. Acta Universitatis Palackianae Olomucensis Facultatis Medicae 139: 7-16.
2. Vavreckova, C., I. Gawlik, and K. Muller. 1996. Benzophenanthridine alkaloids of Chelidonium majus; I. Inhibition of 5- and 12-lipoxygenase by a non-redox mechanism. Planta Medica 62: 397-401. (Pubitemid 26370327)
3. Siomboing, X., B. Gressier, T. Dine, C. Brunet, M. Luyckx, M. Cazin, and J.C. Cazin. 2001. Investigation of the inhibitory effects of chelerythrine chloride on the translocation of the protein kinase C beta I, beta II, zeta in human neutrophils. Farmaco 56: 859-865. (Pubitemid 33713056)
4. Vrba, J., Z. Dvorak, J. Ulrichova, and M. Modriansky. 2008. Conventional protein kinase C isoenzymes undergo dephosphorylation in neutrophil-like HL-60 cells treated by chelerythrine or sanguinarine. Cell Biology and Toxicology 24: 39-53.
5. Shemon, A.N., R. Sluyter, A.D. Conigrave, and J.S. Wiley. 2004. Chelerythrine and other benzophenanthridine alkaloids block the human P2X(7) receptor. British Journal of Pharmacology 142: 1015-1019. (Pubitemid 39037051)
6. Vogt, A., A. Tamewitz, J. Skoko, R.P. Sikorski, K.A. Giuliano, and J.S. Lazo. 2005. The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1. Journal of Biological Chemistry 280: 19078-19086. (Pubitemid 41379614)
7. Lombardini, J.B. 1995. Paradoxical stimulatory effect of the kinase inhibitor chelerythrine on the phosphorylation of a 20 K Mr protein present in the mitochondrial fraction of rat retina. Brain Research 673: 194-198.
8. Herbert, J.M., P. Savi, M.C. Laplace, A. Dumas, and F. Dol. 1993. Chelerythrine, a selective protein kinase C inhibitor, counteracts pyrogen-induced expression of tissue factor without effect on thrombomodulin down-regulation in endothelial cells. Thrombosis Research 71(6): 487-493. (Pubitemid 23248669)
9. Wang, B.H., Z.X. Lu, and G.M. Polya. 1997. Inhibition of eukaryote protein kinases by isoquinoline and oxazine alkaloids. Planta Medica 63: 494-498. (Pubitemid 28035441)
10. Serhan, C.N., and J. Savill. 2005. Resolution of inflammation: the beginning programs the end. Nature Immunology 6: 1191-1197. (Pubitemid 43045627)
11. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. The FASEB Journal 6: 3051-3064.
12. Beutler, B., and A. Cerami. 1989. The biology of cachectin/TNF-α primary mediator of the host response. Annual Review of Immunology 7: 625-655. (Pubitemid 19138027)
13. Kontoyiannis, D., M. Pasparakis, T.T. Pizarro, F. Cominelli, and G. Kollias. 1999. Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU rich elements: implications for joint and gutassociated immunopathologies. Immunity 10: 387-398. (Pubitemid 29165293)
14. Nagai, H., H. Kumamoto, M. Fukuda, and T. Takahashi. 2003. Inducible nitric oxide synthase and apoptosis-related factors in the synovial tissues of temporomandibular joints with internal derangement and osteoarthritis. Journal of Oral and Maxillofacial Surgery 61: 801-807. (Pubitemid 36754033)
15. Chi, Y.S., H. Lim, H. Park, and H.P. Kim. 2003. Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochemical Pharmacology 66: 1271-1278. (Pubitemid 37130302)
16. Goto, H., and S. Nakamura. 1980. Liberation of endotoxin from Escherichia coli by addition of antibiotics. Japanese Journal of Experimental Medicine 50: 35-43. (Pubitemid 10090919)
17. Morrison, D.C., R.L. Danner, C.A. Dinarello, R.S. Munford, C. Natanson, and M. Pollack. 1994. Bacterial endotoxins and pathogenesis of Gram-negative infections: current status and future direction. Journal of Endotoxin Research 1: 71-83. (Pubitemid 2119247)
18. Blenman, K.R., F.R. Bahjat, L.L. Moldawer, and L. Morel. 2004. Aberrant signaling in the TNFalpha/TNF receptor 1 pathway of the NZM2410 lupus-prone mouse. Clinical Immunology 110: 124-133. (Pubitemid 38296702)
19. Ma, X.J. 2001. TNF-alpha and IL-12: a balancing act in macrophage functioning. Microbes and Infection 3: 121-129.
20. Di Santo, E., M. Sironi, P. Pozzi, P. Gnocchi, A.M. Isetta, A. Delvaux, M. Goldman, A. Marchant, and P. Ghezzi. 1995. Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin-1β production in the brain without affecting the activation of the hypothalamus-pituitary adrenal axis. Neuroimmunomodulation 2: 149-154.
21. Fattori, E., M. Cappelletti, P. Costa, C. Sellitto, L. Cantoni, M. Carelli, R. Faggioni, G. Fantuzzi, P. Ghezzi, and V. Poli. 1994. Defective inflammatory response in IL-6 deficient mice. The Journal of Experimental Medicine 180: 1243-1250. (Pubitemid 24289598)
22. De Stefano, D., M.C. Maiuri, B. Iovine, A. Ialenti, M.A. Bevilacqua, and R. Carnuccio. 2006. The role of NF-kappa B, IRF-1, and STAT-1 alpha transcription factors in the iNOS gene induction by gliadin and IFN-gamma in RAW 264.7 macrophages. Journal of Molecular Medicine 84: 65-74. (Pubitemid 43099525)
23. Pearson, G., F. Robinson, T. Beers Gibson, B. Xu, M. Karandikar, and K. Berman. 2001. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocrine Reviews 22: 153-183. (Pubitemid 32458157)
24. Feng, W.G., Y.B. Wang, J.S. Zhang, X.Y. Wang, C.L. Li, and Z.L. Chang. 2002. cAMP elevators inhibit LPS-induced IL-12 p40 expression by interfering with phosphorylation of p38 MAPK in murine peritoneal macrophages. Cell Research 12: 331-337. (Pubitemid 135708345)
25. Chen, T.H., Y.C. Kao, B.C. Chen, C.H. Chen, P. Chan, and H.M. Lee. 2006. Dipyridamole activation of mitogen-activated protein kinase phosphatase-1 mediates inhibition of lipopolysaccharideinduced cyclooxygenase-2 expression in RAW 264.7 cells. European Journal of Pharmacology 541: 138-146. (Pubitemid 43903482)
26. Collart, M.A., P. Baeuerle, and P. Vassalli. 1990. Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Molecular and Cellular Biology 10: 1498-1506.
27. Chen, C.C., and J.K. Wang. 1999. P38 but not p44/42 mitogenactivated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. Molecular Pharmacology 55: 481-488.
28. Ajizian, S.J., B.K. English, and E.A. Meals. 1999. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon gamma. Journal of Infectious Diseases 179: 939-944. (Pubitemid 29159340)
29. Carter, A.B., K.L. Knudtson, M.M. Monick, and G.W. Hunninghake. 1999. The p38 mitogen-activated protein kinase is required for NF-kappa B-dependent gene expression. The role of TATA-binding protein (TBP). Journal of Biological Chemistry 274: 30858-30863.
30. Blenis, J. 1993. Signal transduction via MAP kinase: proceed at your own RSK. Proceedings of the National Academy of Sciences of the United States of America 90: 5889-5892. (Pubitemid 23191418)
31. Niu, X.F., P. Zhou, W.F. Li, and H.B. Xu. 2011. Effects of CHE, a specific inhibitor of cyclooxygenase-2, on acute inflammation in mice. Fitoterapia 82: 620-625.
32. Chio, C.C., Y.H. Chang, Y.W. Hu, K.H. Chi, and W.W. Lin. 2004. Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Cellular Signalling 16: 565-575.
33. Nemeth, Z.H., S.J. Leibovich, E.A. Deitch, B. Sperlagh, L. Virag, E.S. Vizi, C. Szabo, and G. Hasko. 2003. Adenosine stimulates CREB activation in macrophages via a p38 MAPK-mediated mechanism. Biochemical and Biophysical Research Communications 312: 883-888. (Pubitemid 37490900)
34. Guha, M., and N. Mackman. 2001. LPS induction of gene expression in human monocytes. Cellular Signalling 13: 85-94. (Pubitemid 32222977)
35. Kilbourn, R.G., and P. Belloni. 1990. Endothelial cell production of nitric oxide in response to interferon-γ in combination with tumor necrosis factor, interleukin-1, or endotoxin. Journal of the National Cancer Institute 82: 772-776. (Pubitemid 20159277)
36. Murakami, A., D. Takahashi, K. Hagihara, K. Koshimizu, and H. Ohigashi. 2003. Combinatorial effects of nonsteroidal anti-inflammatory drugs and food constituents on production of prostaglandin E2 and tumor necrosis factor alpha in RAW264.7 murine macrophages. Bioscience, Biotechnology, and Biochemistry 67: 1056-1062. (Pubitemid 39251864)
37. Albina, J.L., and J.S. Reichner. 1998. Role of nitric oxide mediation of macrophage cytotoxicity and apoptosis. Cancer and Metastasis Reviews 17: 39-53. (Pubitemid 28194645)
38. Boucher, J.L., C. Moali, and J.P. Tenu. 1999. Nitric oxide biosynthesis: nitric oxide synthase inhibitors and arginase competition for L-arginine utilization. Cellular and Molecular Life Sciences 55: 1015-1028. (Pubitemid 29361068)
39. Lee, H.J., E.A. Hyun, W.J. Yoon, B.H. Kim, M.H. Rhee, H.K. Kang, J.Y. Cho, and E.S. Yoo. 2006. In vitro anti-inflammatory and anti-oxidative effects of Cinnamomum camphora extracts. Journal of Ethnopharmacology 103: 208-216. (Pubitemid 41796919)
40. Arenzana-Seisdedos, F., and J. Virelizier. 1983. Interferons as macrophage-activating factors. II. Enhanced secretion of interleukin 1 by lipopolysaccharide-stimulated human monocytes. European Journal of Immunology 13: 437-440. (Pubitemid 13060105)
41. Chokri, M., M. Freudenberg, C. Galanos, P. Poindron, and J. Bartholeyns. 1989. Antitumoral effects of lipopolysaccharide, tumor necrosis factor, interferon and activated macrophages: synergism and tissue distribution. Anticancer Research 9: 1185-1190. (Pubitemid 19266378)
42. Stuehr, D.J., and M.A. Marletta. 1987. Synthesis of nitrite and nitrate in macrophage cell lines. Cancer Research 47: 5590-5594. (Pubitemid 18046749)
43. Keller, R., R. Keist, and K. Frei. 1990. Lymphokines and bacteria that induce tumoricidal activity, trigger a different secretory response in macrophages. European Journal of Immunology 20: 695-698. (Pubitemid 20101314)
44. Wu, C.H., T.L. Chen, T.G. Chen, W.P. Ho, W.T. Chiu, and R.M. Chen. 2003. Nitric oxide modulates pro- and anti-inflammatory cytokines in lipopolysaccharide-activated macrophages. The Journal of Trauma 55: 540-545.
45. Dong, Z., C.A. O'Brian, and I.J. Fidler. 1993. Activation of tumoricidal properties in macrophages by lipopolysaccharide requires protein tyrosine kinase activity. Journal of Leukocyte Biology 53: 53-60. (Pubitemid 23048048)
46. Um, S.H., D.K. Rhee, and S. Pyo. 2002. Involvement of protein kinase C and tyrosine kinase in tumoricidal activation of macrophage induced by Streptococcus pneumoniae type II capsular polysaccharide. International Immunopharmacology 2: 129-137. (Pubitemid 33086810)
47. Jaramillo, M., P.H. Naccache, and M. Olivier. 2004. Monosodium urate crystals synergize with IFN-gamma to generate macrophage nitric oxide involvement of extracellular signal-regulated kinase 1/2 and NF-kappa B. Journal of Immunology 172: 5734-5742. (Pubitemid 38542079)
48. Guha, M., and N. Mackman. 2001. LPS induction of gene expression in human monocytes. Cellular Signalling 13: 85-94. (Pubitemid 32222977)
49. Caamano, J., and C.A. Hunter. 2002. NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clinical Microbiology Reviews 15: 414-429. (Pubitemid 34761350)
50. Schorey, J.S., and A.M. Cooper. 2003. Macrophage signalling upon mycobacterial infection: the MAP kinases lead the way. Cellular Microbiology 5: 133-142. (Pubitemid 36348030)